Genedata launched an electronic lab notebook on October 28, integrating experimental documentation with the scientific data already held in its biopharmaceutical research platform.
The Danaher company said the notebook connects records to molecules, samples, process parameters and assay results across discovery and development. Its intended uses include work on biologics, antibody-drug conjugates, cell and gene therapies, and peptides.
According to the announcement, documentation remains connected to a candidate’s development history rather than being transferred between separate applications. The company said this structure is intended to make earlier experiments easier to search and reuse.
The notebook also links experiments to sample identities, properties, lineage and physical locations. Related laboratory information and workflow tools coordinate requests among internal laboratories and outside research or manufacturing organizations.
President Othmar Pfannes said aligning scientific concepts and metadata would help researchers and AI applications use the information consistently.
These are Genedata’s descriptions of the product. The launch announcement does not provide independent measurements of time savings, improved research results or successful drug development attributable to the notebook.
Sources Genedata October 28 product announcement: https://www.prnewswire.com/news-releases/genedata-launches-fully-integrated-electronic-lab-notebook-to-help-biopharma-rd-teams-move-faster-302922550.html